CIBC Bancorp USA’s Hologic HOLX Stock Holding History

CIBC Bancorp USA’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-74,778	Closed	-$5.66M	–	1987
2026 Q1	$5.66M	Buy	+74,778	New	+$5.62M	0.01%	671
2025 Q3	$2.07M	Buy	+30,702	New	+$2.04M	0.01%	586

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CIBC Bancorp USA's HOLX Position: Q2 2026 in Review

CIBC Bancorp USA sold out of Hologic (HOLX) in Q2 2026, closing a stake of 74,778 shares — an estimated $5.66M sold.

CIBC Bancorp USA first reported a position in HOLX in Q3 2025 and held it in 2 quarters. The position peaked at $5.66M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

CIBC Bancorp USA reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
CIBC Bancorp USA sold 74,778 Hologic shares in Q2 2026, an estimated $5.66M.
CIBC Bancorp USA first reported a position in Hologic in Q3 2025 and held it in 2 quarters.
CIBC Bancorp USA's Hologic position peaked at $5.66M in Q1 2026.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.